Sutro Biopharma, Inc. (STRO) vs Yarrow Bioscience, Inc (YARW)
Sutro Biopharma, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Sutro Biopharma, Inc. and Yarrow Bioscience, Inc are of similar size ($260.5M and $246.0M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −56.3%. Sutro Biopharma, Inc. has the higher net margin (−395.3% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Sutro Biopharma, Inc. leads on 8 and Yarrow Bioscience, Inc on 6.
Valuation
Profitability
| Metric | STRO | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (319.57%) | (4,134.44%) | 0.00% |
| Net margin | (395.25%) | (3,881.54%) | 0.00% |
| Free cash flow margin | (318.63%) | (3,513.07%) | 0.00% |
| Return on equity | 266.76% | (61.40%) | (57.72%) |
| Return on assets | (79.08%) | (54.77%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack